The percentage of NY-ESO-1-specific CD8+ T cells was significantly lower in KYNhi MM patients and was negatively correlated with Treg-cell expansion, implying that IDO1 activity may affect the anti-myeloma immune response either directly or indirectly, through the Treg compartment. This evidence concerns the gene IDO1 and plasma cell myeloma.